M. Seidensticker Et Al. , "Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial," JHEP Reports , vol.5, no.5, 2023
Seidensticker, M. Et Al. 2023. Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial. JHEP Reports , vol.5, no.5 .
Seidensticker, M., Öcal, O., Schütte, K., Malfertheiner, P., Berg, T., Loewe, C., ... Klümpen, H. J.(2023). Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial. JHEP Reports , vol.5, no.5.
Seidensticker, Max Et Al. "Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial," JHEP Reports , vol.5, no.5, 2023
Seidensticker, Max Et Al. "Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial." JHEP Reports , vol.5, no.5, 2023
Seidensticker, M. Et Al. (2023) . "Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial." JHEP Reports , vol.5, no.5.
@article{article, author={Max Seidensticker Et Al. }, title={Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial}, journal={JHEP Reports}, year=2023}